Results 81 to 90 of about 2,440,721 (342)

Multivariate genetic divergence among sugarcane clones by multivariate analysis associated with mixed models

open access: yesSemina: Ciências Agrárias, 2014
This work had the aim to evaluate the genetic divergence in sugarcane clones using the methodology of graphic dispersion by principal components analysis associated to linear mixed models, indentifying the more divergent and productive genotypes with ...
Valéria Rosa Lopes   +4 more
doaj   +1 more source

Relationship Between Neurologic Symptoms and Signs and FMR1 Genotype in Premutation Carriers

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background and Objectives Fragile X‐associated Tremor/Ataxia Syndrome (FXTAS) is the most severe late‐onset condition caused by a premutation in the FMR1 gene, characterized by expanded CGG triplet repeats of 55–200. Clinical presentations of FXTAS, including gait ataxia, kinetic tremor, cognitive decline, and rare Parkinsonism, are linked to ...
Flora Tassone   +8 more
wiley   +1 more source

Multivariate Statistical Analysis and Required Sample Size

open access: yesJournal of Nursology, 2022
Ömer AKBULUT, Cantürk ÇAPIK
doaj   +1 more source

KOMPARASI ANALISIS GEROMBOL (CLUSTER) DAN BIPLOT DALAM PENGELOMPOKAN

open access: yesE-Jurnal Matematika, 2013
One of functions of multivariate analysis is to group data. Multivariate analysis often used in grouping  data are cluster analysis and biplot analysis. In this paper, a comparative analysis will be made between clusters analysis and biplot analysis  for
I MADE ANOM ARIAWAN   +2 more
doaj   +1 more source

Approximate null distribution of the largest root in multivariate analysis

open access: yes, 2010
The greatest root distribution occurs everywhere in classical multivariate analysis, but even under the null hypothesis the exact distribution has required extensive tables or special purpose software.
Johnstone, Iain M.
core   +1 more source

Predictive Ability of Plasma p‐tau217 for β‐Amyloid Status: A Prospective Multicenter Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Plasma tau phosphorylated at threonine 217 (p‐tau217) measured with fully automated platforms has shown high accuracy for Alzheimer's disease (AD) diagnosis, but real‐world multicenter data remain limited. We aimed to validate the diagnostic performance of p‐tau217 for identifying AD pathology in a real‐world multicenter cohort ...
Miquel Massons   +33 more
wiley   +1 more source

Understanding Further the Phenotypic Spectrum of Central Nervous System Inflammatory Demyelinating Disorders Using Unsupervised Clustering

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Central nervous system (CNS) inflammatory demyelinating syndromes, including multiple sclerosis (MS), aquaporin‐4 antibody–positive neuromyelitis optica spectrum disorder (AQP4 + NMOSD), and myelin oligodendrocyte glycoprotein (MOG) antibody–associated disease (MOGAD), occasionally overlap.
Bade Gulec   +6 more
wiley   +1 more source

Multivariate discriminant analysis of the electrocardiogram

open access: yesРоссийский технологический журнал
Objectives. The article presents a study of heart rate variability using multivariate discriminant analysis. Representing an effective statistical method of classification, discriminant analysis can be used to divide objects into groups based on ...
Polina A. Sakharova   +1 more
doaj   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy